drugset / Trial / NCT05874336

An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol

NCT05874336

NaSingle-groupOpen-labelTreatment

Summary

A two-part open-label study to assess the absolute bioavailability of aramchol and the mass balance recovery, metabolite profile and identification of metabolite structures for \[14C\]-aramchol in healthy male subjects

Timeline

Start
2020-06-17
Primary completion
2020-08-11
Completion
2020-08-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Aramchol Other / unclassified